Identification of genetic changes associated with drug resistance by reverse in situ hybridization.

The molecular cytogenetic techniques of comparative genomic hybridization (CGH) and reverse in situ hybridization (REVISH) allow the entire genomes of tumours to be screened for genetic changes without the requirement for specific probes or markers. In order to define the ability of REVISH to detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoare, S. F., Freeman, C. A., Coutts, J. C., Varley, J. M., James, L., Keith, W. N.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063285/
https://www.ncbi.nlm.nih.gov/pubmed/9010038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063285/
https://www.ncbi.nlm.nih.gov/pubmed/9010038

Ejemplares similares